- ►endojournals.org C Knauf, PD Cani, A Ait-Belgnaoui, A Benani, … - Endocrinology, 2008 - Endocrine Soc Glucagon-like peptide-1 (GLP-1) is a peptide released by the intestine and the
brain. We previously demonstrated that brain GLP-1 increases glucose-dependent
hyperinsulinemia and insulin resistance. These two features are major ... Cited by 10 - Related articles - All 5 versions
- ►glucagon.com [PDF] JE Ayala, DP Bracy, FD James, BM Julien, … - Endocrinology, 2009 - Endocrine Soc Glucagon-like peptide-1 (GLP-1) diminishes postmeal glucose excursions by
enhancing insulin secretion via activation of the β-cell GLP-1 receptor
(Glp1r). GLP-1 may also control glucose levels through mechanisms that are ... Cited by 6 - Related articles - All 4 versions
O Schmitz - Journal of Clinical Endocrinology & Metabolism, 2008 - Endocrine Soc The pandemic explosion of type 2 diabetes incidence is well established, due to
dramatic global changes in lifestyle over the past few decades and in the
foreseeable future. To alter the course of this trend may take, at best, up ... Cited by 2 - Related articles - BL Direct - All 2 versions
SL Samson, EV Gonzalez, V Yechoor, M Bajaj … - Molecular therapy: the journal of the American Society …, 2008 - pubmedcentral.nih.gov Exendin 4 (Ex4) is a glucagon-like peptide-1 receptor (GLP- 1R) agonist which is
available as a short-acting injectable treatment for type 2 diabetes. Our aim
was to characterize the long-term effects of elevated steady-state levels ... Cited by 1 - Related articles - All 5 versions
- ►endojournals.org [PDF] H Duez, AC Smith, C Xiao, A Giacca, L Szeto, … - Endocrinology, 2008 - Endocrine Soc Page 1. 1 Acute DPP-4 Inhibition rapidly Enhances Insulin-mediated
Suppression of Endogenous Glucose Production in Mice Hélène ... Cited by 1 - Related articles
- ►glucagon.com [PDF] H Duez, AC Smith, C Xiao, A Giacca, L Szeto, … - Endocrinology, 2009 - Endocrine Soc Pharmacological approaches that enhance incretin action for the treatment of
type 2 diabetes mellitus have recently been developed, ie. injectable
glucagon-like peptide-1 receptor (GLP-1R) agonists with prolonged plasma ... Related articles - All 3 versions
PIN DIABETES - mc.vanderbilt.edu There are few methodologies that have done more to advance our understanding of
insulin action in humans and animals than the hyperinsulinemic- euglycemic clamp
(henceforth referred to as the insulin clamp or clamp). The clamp was first ... Related articles - View as HTML
H Duez, AC Smith, C Xiao, A Giacca, L Szeto, … - glucagon.com Page 1. 1 Acute DPP-4 Inhibition rapidly Enhances Insulin-mediated
Suppression of Endogenous Glucose Production in Mice Hélène ... Related articles - View as HTML